Horan Capital Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Horan Capital Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75	Closed	-$7K	–	302
2020 Q3	$7K	Buy	+75	New	+$8.63K	﹤0.01%	270
2020 Q1	–	Sell	-150	Closed	-$16K	–	276
2019 Q4	$16K	Hold	150	–	–	0.01%	206
2019 Q3	$17K	Buy	+150	New	+$22.8K	0.01%	210
2019 Q2	–	Sell	-150	Closed	-$25K	–	261
2019 Q1	$25K	Buy	+150	New	+$22.3K	0.02%	180

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Horan Capital Advisors's GWPH Position: Q4 2020 in Review

Horan Capital Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 75 shares — an estimated $7K sold.

Horan Capital Advisors first reported a position in GWPH in Q1 2019 and held it in 4 quarters. The position peaked at $25K in Q1 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Horan Capital Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Horan Capital Advisors sold 75 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $7K.
Horan Capital Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
Horan Capital Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $25K in Q1 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.